NCT01854268

Brief Summary

Cough is a defensive behavior that involves three stages. A large inspiratory phase, a compression phase where the vocal folds close and subglottal pressure is developed, and an expiratory phase. Cough serves to protect the upper and lower airways from material such as liquids, solids, or saliva, that have been aspirated. There are two types of cough: voluntary and reflex cough. Voluntary cough involves a cough to command. Reflex cough is a cough that is generated secondary to a stimulus in or near the airway. There has been some research regarding the differences between voluntary and reflex cough. However, no research has described the differences in airflow or movement pattern (kinematics) between the two types of cough. This study seeks to determine the respiratory kinematics and airflow differences between voluntary and reflex cough in healthy participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started May 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 15, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
10 months until next milestone

Results Posted

Study results publicly available

March 4, 2015

Completed
Last Updated

February 9, 2022

Status Verified

February 1, 2022

Enrollment Period

1 year

First QC Date

May 10, 2013

Results QC Date

December 10, 2014

Last Update Submit

February 3, 2022

Conditions

Keywords

cough

Outcome Measures

Primary Outcomes (1)

  • Lung Volume Initiation

    Respiratory kinematic measure: lung volume initiation (LVI) Lung volume initiation is a measure of the volume of air in the lungs prior to a respiratory task.

    1 hour

Secondary Outcomes (2)

  • Peak Expiratory Airflow Rate

    1 hour

  • Urge-to-cough

    1 hour

Study Arms (1)

Healthy adults who receive capsaicin

EXPERIMENTAL

Single treatment consisting of healthy adults.

Drug: Healthy adults who receive capsaicin

Interventions

Participants will be seated in a comfortable chair and fitted with cotton elastic bands designed to measure changes in chest wall and abdominal movement during cough. The participant will hold a facemask attached to a pneumotachograph, nebulized, and dosimeter. The participant will receive 3 nebulized doses of 200 microMolar capsaicin through the facemask. The participants will have a minute in between each presentation and water will be available at all times.

Also known as: capsaicin
Healthy adults who receive capsaicin

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults between the ages of 18-80 years.
  • Ability to provide informed consent.

You may not qualify if:

  • No history of smoking within the last 5 years as this reduces the sensitivity to capsaicin
  • No history of neurological disease (i.e. Parkinson's disease, stroke, traumatic brain injury, etc.)
  • No known allergy to capsaicin
  • No history of respiratory disease (i.e. asthma, chronic obstructive pulmonary disease, or respiratory infection within the last 5 weeks.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida, Dauer Hall

Gainesville, Florida, 32611, United States

Location

MeSH Terms

Conditions

Cough

Interventions

Capsaicin

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Polyunsaturated AlkamidesAmidesOrganic ChemicalsAlkenesHydrocarbons, AcyclicHydrocarbonsCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicSolanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsFatty Acids, MonounsaturatedFatty Acids, UnsaturatedFatty AcidsLipids

Results Point of Contact

Title
Alexandra E. Brandimore, M.A. CCC/SLP
Organization
University of Florida

Study Officials

  • Alexandra E. Brandimore, M.A.

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2013

First Posted

May 15, 2013

Study Start

May 1, 2013

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

February 9, 2022

Results First Posted

March 4, 2015

Record last verified: 2022-02

Locations